Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BIO |
---|---|---|
09:32 ET | 531 | 337.985 |
09:33 ET | 100 | 338.5 |
09:37 ET | 100 | 339.745 |
09:42 ET | 300 | 340.6 |
09:44 ET | 100 | 340.07 |
09:46 ET | 656 | 342.29 |
09:48 ET | 100 | 340.065 |
09:57 ET | 300 | 338.675 |
10:00 ET | 200 | 339 |
10:02 ET | 900 | 338.075 |
10:04 ET | 800 | 338.59 |
10:06 ET | 275 | 339.5248 |
10:08 ET | 100 | 340.85 |
10:09 ET | 100 | 340.455 |
10:18 ET | 100 | 339.165 |
10:24 ET | 100 | 338.93 |
10:26 ET | 200 | 339.035 |
10:27 ET | 351 | 339.035 |
10:29 ET | 271 | 339.025 |
10:33 ET | 100 | 339.97 |
10:40 ET | 100 | 339.305 |
10:42 ET | 579 | 339.7177 |
10:45 ET | 471 | 340.181 |
10:47 ET | 200 | 340.73 |
10:49 ET | 107 | 340.08 |
10:54 ET | 100 | 340.955 |
10:56 ET | 200 | 340.425 |
10:58 ET | 100 | 339.9345 |
11:00 ET | 700 | 339.86 |
11:02 ET | 100 | 340.445 |
11:03 ET | 100 | 340.37 |
11:14 ET | 200 | 340.33 |
11:18 ET | 100 | 340.495 |
11:32 ET | 100 | 340.905 |
11:39 ET | 300 | 339.72 |
11:41 ET | 100 | 339.83 |
11:52 ET | 200 | 339.55 |
11:59 ET | 100 | 339.82 |
12:01 ET | 225 | 340.61 |
12:14 ET | 100 | 340.295 |
12:17 ET | 100 | 340.355 |
12:19 ET | 100 | 339.63 |
12:26 ET | 100 | 340.04 |
12:30 ET | 100 | 339.965 |
12:32 ET | 100 | 339.72 |
12:37 ET | 123 | 340.33 |
12:39 ET | 143 | 339.8925 |
12:51 ET | 600 | 341.14 |
12:53 ET | 300 | 341.09 |
12:55 ET | 300 | 341.09 |
12:57 ET | 834 | 339.97 |
01:00 ET | 16533 | 340.53 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Bio Rad Laboratories Inc | 9.5B | -12.5x | --- |
Teleflex Inc | 8.9B | 38.2x | +12.49% |
Masimo Corp | 9.2B | 118.7x | -15.37% |
Penumbra Inc | 9.4B | 283.8x | +65.82% |
Repligen Corp | 8.2B | -488.9x | +15.08% |
Bausch + Lomb Corp | 7.0B | -18.9x | --- |
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.5B |
---|---|
Revenue (TTM) | $2.6B |
Shares Outstanding | 28.0M |
Bio Rad Laboratories Inc does not pay a dividend. | |
Beta | 0.90 |
EPS | $-27.32 |
Book Value | $306.51 |
P/E Ratio | -12.5x |
Price/Sales (TTM) | 3.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | 11.86% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.